Structure

Physi-Chem Properties

Molecular Weight:  562.35
Volume:  587.578
LogP:  3.311
LogD:  3.136
LogS:  -4.475
# Rotatable Bonds:  7
TPSA:  141.36
# H-Bond Aceptor:  8
# H-Bond Donor:  4
# Rings:  4
# Heavy Atoms:  8

MedChem Properties

QED Drug-Likeness Score:  0.285
Synthetic Accessibility Score:  5.427
Fsp3:  0.844
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.996
MDCK Permeability:  1.3942893929197453e-05
Pgp-inhibitor:  0.989
Pgp-substrate:  0.046
Human Intestinal Absorption (HIA):  0.029
20% Bioavailability (F20%):  0.632
30% Bioavailability (F30%):  0.815

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.817
Plasma Protein Binding (PPB):  73.0634536743164%
Volume Distribution (VD):  0.504
Pgp-substrate:  19.764251708984375%

ADMET: Metabolism

CYP1A2-inhibitor:  0.004
CYP1A2-substrate:  0.115
CYP2C19-inhibitor:  0.017
CYP2C19-substrate:  0.795
CYP2C9-inhibitor:  0.034
CYP2C9-substrate:  0.33
CYP2D6-inhibitor:  0.004
CYP2D6-substrate:  0.083
CYP3A4-inhibitor:  0.721
CYP3A4-substrate:  0.444

ADMET: Excretion

Clearance (CL):  5.273
Half-life (T1/2):  0.78

ADMET: Toxicity

hERG Blockers:  0.02
Human Hepatotoxicity (H-HT):  0.129
Drug-inuced Liver Injury (DILI):  0.082
AMES Toxicity:  0.033
Rat Oral Acute Toxicity:  0.651
Maximum Recommended Daily Dose:  0.904
Skin Sensitization:  0.101
Carcinogencity:  0.804
Eye Corrosion:  0.003
Eye Irritation:  0.013
Respiratory Toxicity:  0.629

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC280782

Natural Product ID:  NPC280782
Common Name*:   Hemslecin A
IUPAC Name:   [(6R)-6-hydroxy-2-methyl-5-oxo-6-[(2S,3S,8S,9R,10R,13R,14S,16R,17R)-2,3,16-trihydroxy-4,4,9,13,14-pentamethyl-11-oxo-1,2,3,7,8,10,12,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl]heptan-2-yl] acetate
Synonyms:   Hemslecin A
Standard InCHIKey:  LKYNAQSYQLFTCM-GYXNDICUSA-N
Standard InCHI:  InChI=1S/C32H50O8/c1-17(33)40-27(2,3)13-12-23(36)32(9,39)25-21(35)15-29(6)22-11-10-18-19(14-20(34)26(38)28(18,4)5)31(22,8)24(37)16-30(25,29)7/h10,19-22,25-26,34-35,38-39H,11-16H2,1-9H3/t19-,20+,21-,22+,25+,26-,29+,30-,31+,32+/m1/s1
SMILES:  CC(=O)OC(C)(C)CCC(=O)[C@@](C)([C@H]1[C@@H](C[C@@]2(C)[C@@H]3CC=C4[C@@H](C[C@@H]([C@H](C4(C)C)O)O)[C@]3(C)C(=O)C[C@]12C)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL2332392
PubChem CID:   181183
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000258] Steroids and steroid derivatives
        • [CHEMONTID:0001686] Cucurbitacins

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO33474 hemsleya penxianensis Species Cucurbitaceae Eukaryota n.a. n.a. n.a. PMID[24717151]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT323 Cell Line SW-620 Homo sapiens IC50 = 1.11 ug.mL-1 PMID[543713]
NPT407 Cell Line COLO 205 Homo sapiens IC50 = 1.09 ug.mL-1 PMID[543713]
NPT2 Others Unspecified Ratio CC50/IC50 = 5.8 n.a. PMID[543712]
NPT963 Organism Hepatitis B virus Hepatitis B virus IC50 = 11200.0 nM PMID[543712]
NPT2 Others Unspecified Ratio CC50/IC50 < 1.0 n.a. PMID[543712]
NPT963 Organism Hepatitis B virus Hepatitis B virus IC50 > 66200.0 nM PMID[543712]
NPT27 Others Unspecified CC50 = 66200.0 nM PMID[543712]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 = 11.53 ug.mL-1 PMID[543713]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC280782 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9417 High Similarity NPC196528
0.9223 High Similarity NPC191892
0.9143 High Similarity NPC165873
0.9091 High Similarity NPC471854
0.9057 High Similarity NPC94529
0.9027 High Similarity NPC222688
0.9018 High Similarity NPC471406
0.9009 High Similarity NPC311554
0.9009 High Similarity NPC257457
0.8991 High Similarity NPC962
0.8991 High Similarity NPC202889
0.8868 High Similarity NPC278628
0.8868 High Similarity NPC231530
0.886 High Similarity NPC65858
0.885 High Similarity NPC109973
0.8829 High Similarity NPC266728
0.8829 High Similarity NPC49492
0.8829 High Similarity NPC270958
0.8818 High Similarity NPC194100
0.8818 High Similarity NPC250109
0.8796 High Similarity NPC304495
0.8785 High Similarity NPC59530
0.8783 High Similarity NPC135038
0.8783 High Similarity NPC43252
0.8774 High Similarity NPC471293
0.8774 High Similarity NPC29705
0.8762 High Similarity NPC473928
0.8727 High Similarity NPC71348
0.8707 High Similarity NPC473255
0.8692 High Similarity NPC475571
0.8679 High Similarity NPC140723
0.8679 High Similarity NPC117185
0.8673 High Similarity NPC118638
0.8661 High Similarity NPC328374
0.8661 High Similarity NPC148458
0.8661 High Similarity NPC251236
0.8661 High Similarity NPC96312
0.8661 High Similarity NPC40632
0.8654 High Similarity NPC477854
0.8649 High Similarity NPC52634
0.8649 High Similarity NPC49451
0.8649 High Similarity NPC108721
0.8649 High Similarity NPC73300
0.8641 High Similarity NPC49371
0.8636 High Similarity NPC43775
0.8621 High Similarity NPC267822
0.8611 High Similarity NPC144854
0.8611 High Similarity NPC3316
0.8609 High Similarity NPC470921
0.8596 High Similarity NPC475041
0.8585 High Similarity NPC22388
0.8585 High Similarity NPC477054
0.8584 High Similarity NPC239273
0.8583 High Similarity NPC471855
0.8583 High Similarity NPC473519
0.8583 High Similarity NPC473805
0.8571 High Similarity NPC83709
0.8571 High Similarity NPC473798
0.8571 High Similarity NPC167974
0.8559 High Similarity NPC470882
0.8559 High Similarity NPC475524
0.8559 High Similarity NPC474516
0.8559 High Similarity NPC100267
0.8559 High Similarity NPC170487
0.8547 High Similarity NPC169818
0.8545 High Similarity NPC76084
0.8545 High Similarity NPC197428
0.8544 High Similarity NPC469599
0.8534 High Similarity NPC269642
0.8532 High Similarity NPC154608
0.8532 High Similarity NPC192813
0.8532 High Similarity NPC472219
0.8532 High Similarity NPC293850
0.8532 High Similarity NPC472217
0.8532 High Similarity NPC472218
0.8532 High Similarity NPC277017
0.8532 High Similarity NPC258323
0.8519 High Similarity NPC475494
0.8519 High Similarity NPC149047
0.8512 High Similarity NPC102015
0.8496 Intermediate Similarity NPC474734
0.8496 Intermediate Similarity NPC235539
0.8496 Intermediate Similarity NPC134869
0.8496 Intermediate Similarity NPC152199
0.8491 Intermediate Similarity NPC477052
0.8491 Intermediate Similarity NPC477051
0.8491 Intermediate Similarity NPC477053
0.8482 Intermediate Similarity NPC317210
0.8476 Intermediate Similarity NPC119036
0.8468 Intermediate Similarity NPC214797
0.8468 Intermediate Similarity NPC472003
0.8468 Intermediate Similarity NPC118860
0.8468 Intermediate Similarity NPC231589
0.8462 Intermediate Similarity NPC477853
0.8462 Intermediate Similarity NPC42042
0.8462 Intermediate Similarity NPC173272
0.8455 Intermediate Similarity NPC11710
0.8455 Intermediate Similarity NPC141350
0.8455 Intermediate Similarity NPC258543
0.8455 Intermediate Similarity NPC214644
0.8455 Intermediate Similarity NPC241927
0.844 Intermediate Similarity NPC44063
0.844 Intermediate Similarity NPC220229
0.844 Intermediate Similarity NPC83744
0.844 Intermediate Similarity NPC475060
0.844 Intermediate Similarity NPC477916
0.8435 Intermediate Similarity NPC472933
0.8426 Intermediate Similarity NPC204833
0.8426 Intermediate Similarity NPC209502
0.8426 Intermediate Similarity NPC47281
0.8426 Intermediate Similarity NPC475036
0.8426 Intermediate Similarity NPC137657
0.8426 Intermediate Similarity NPC477812
0.8421 Intermediate Similarity NPC97908
0.8421 Intermediate Similarity NPC470854
0.8421 Intermediate Similarity NPC122033
0.8421 Intermediate Similarity NPC473590
0.8421 Intermediate Similarity NPC474654
0.8421 Intermediate Similarity NPC287343
0.8417 Intermediate Similarity NPC471407
0.8411 Intermediate Similarity NPC473788
0.8411 Intermediate Similarity NPC475558
0.8407 Intermediate Similarity NPC326542
0.8407 Intermediate Similarity NPC18547
0.8407 Intermediate Similarity NPC243354
0.8407 Intermediate Similarity NPC474906
0.8403 Intermediate Similarity NPC473265
0.8396 Intermediate Similarity NPC316964
0.8396 Intermediate Similarity NPC218383
0.8396 Intermediate Similarity NPC208358
0.8396 Intermediate Similarity NPC15390
0.8393 Intermediate Similarity NPC207251
0.8393 Intermediate Similarity NPC289312
0.8393 Intermediate Similarity NPC11252
0.8393 Intermediate Similarity NPC152117
0.8393 Intermediate Similarity NPC130427
0.8393 Intermediate Similarity NPC234042
0.8381 Intermediate Similarity NPC475032
0.8381 Intermediate Similarity NPC475033
0.8378 Intermediate Similarity NPC5284
0.8376 Intermediate Similarity NPC28532
0.8365 Intermediate Similarity NPC279974
0.8365 Intermediate Similarity NPC48330
0.8364 Intermediate Similarity NPC217201
0.8364 Intermediate Similarity NPC329417
0.8362 Intermediate Similarity NPC476961
0.8349 Intermediate Similarity NPC49958
0.8349 Intermediate Similarity NPC152695
0.8349 Intermediate Similarity NPC476027
0.8349 Intermediate Similarity NPC171137
0.8349 Intermediate Similarity NPC202167
0.8349 Intermediate Similarity NPC85829
0.8349 Intermediate Similarity NPC102352
0.8349 Intermediate Similarity NPC97202
0.8349 Intermediate Similarity NPC302607
0.8349 Intermediate Similarity NPC48733
0.8349 Intermediate Similarity NPC150531
0.8349 Intermediate Similarity NPC50535
0.8349 Intermediate Similarity NPC50692
0.8349 Intermediate Similarity NPC319077
0.8349 Intermediate Similarity NPC260268
0.8349 Intermediate Similarity NPC28791
0.8349 Intermediate Similarity NPC296945
0.8349 Intermediate Similarity NPC214264
0.8348 Intermediate Similarity NPC297179
0.8348 Intermediate Similarity NPC17772
0.8333 Intermediate Similarity NPC259306
0.8333 Intermediate Similarity NPC470628
0.8333 Intermediate Similarity NPC474046
0.8333 Intermediate Similarity NPC179626
0.8333 Intermediate Similarity NPC207217
0.8333 Intermediate Similarity NPC55954
0.8333 Intermediate Similarity NPC218513
0.8333 Intermediate Similarity NPC196931
0.8319 Intermediate Similarity NPC47113
0.8319 Intermediate Similarity NPC7921
0.8319 Intermediate Similarity NPC15095
0.8319 Intermediate Similarity NPC208998
0.8319 Intermediate Similarity NPC472926
0.8319 Intermediate Similarity NPC174367
0.8318 Intermediate Similarity NPC155974
0.8304 Intermediate Similarity NPC285410
0.8304 Intermediate Similarity NPC201992
0.8304 Intermediate Similarity NPC146945
0.8304 Intermediate Similarity NPC171888
0.8304 Intermediate Similarity NPC470281
0.8304 Intermediate Similarity NPC263827
0.8304 Intermediate Similarity NPC250481
0.8288 Intermediate Similarity NPC284828
0.8288 Intermediate Similarity NPC310546
0.8288 Intermediate Similarity NPC5475
0.8288 Intermediate Similarity NPC173905
0.8288 Intermediate Similarity NPC472216
0.8288 Intermediate Similarity NPC170221
0.8288 Intermediate Similarity NPC118225
0.8288 Intermediate Similarity NPC10064
0.8288 Intermediate Similarity NPC218853
0.8288 Intermediate Similarity NPC2766
0.8276 Intermediate Similarity NPC473203
0.8273 Intermediate Similarity NPC220974

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC280782 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8796 High Similarity NPD6373 Approved
0.8796 High Similarity NPD6372 Approved
0.8727 High Similarity NPD8297 Approved
0.8692 High Similarity NPD6675 Approved
0.8692 High Similarity NPD5739 Approved
0.8692 High Similarity NPD7128 Approved
0.8692 High Similarity NPD6402 Approved
0.8636 High Similarity NPD6650 Approved
0.8636 High Similarity NPD6649 Approved
0.8532 High Similarity NPD6881 Approved
0.8532 High Similarity NPD6899 Approved
0.8532 High Similarity NPD7320 Approved
0.8522 High Similarity NPD6319 Approved
0.8482 Intermediate Similarity NPD4632 Approved
0.8468 Intermediate Similarity NPD8130 Phase 1
0.844 Intermediate Similarity NPD5697 Approved
0.844 Intermediate Similarity NPD5701 Approved
0.8393 Intermediate Similarity NPD6882 Approved
0.8378 Intermediate Similarity NPD7290 Approved
0.8378 Intermediate Similarity NPD6883 Approved
0.8378 Intermediate Similarity NPD7102 Approved
0.8304 Intermediate Similarity NPD6847 Approved
0.8304 Intermediate Similarity NPD6869 Approved
0.8304 Intermediate Similarity NPD6617 Approved
0.8288 Intermediate Similarity NPD6012 Approved
0.8288 Intermediate Similarity NPD6014 Approved
0.8288 Intermediate Similarity NPD6013 Approved
0.8208 Intermediate Similarity NPD4755 Approved
0.8208 Intermediate Similarity NPD6084 Phase 2
0.8208 Intermediate Similarity NPD6083 Phase 2
0.8198 Intermediate Similarity NPD6011 Approved
0.8182 Intermediate Similarity NPD6008 Approved
0.8142 Intermediate Similarity NPD6401 Clinical (unspecified phase)
0.8103 Intermediate Similarity NPD6009 Approved
0.8099 Intermediate Similarity NPD8293 Discontinued
0.8083 Intermediate Similarity NPD7492 Approved
0.8056 Intermediate Similarity NPD5285 Approved
0.8056 Intermediate Similarity NPD5286 Approved
0.8056 Intermediate Similarity NPD4700 Approved
0.8056 Intermediate Similarity NPD4696 Approved
0.8053 Intermediate Similarity NPD4634 Approved
0.8051 Intermediate Similarity NPD6059 Approved
0.8051 Intermediate Similarity NPD6054 Approved
0.8033 Intermediate Similarity NPD7736 Approved
0.8017 Intermediate Similarity NPD6616 Approved
0.8 Intermediate Similarity NPD7604 Phase 2
0.8 Intermediate Similarity NPD6399 Phase 3
0.7983 Intermediate Similarity NPD5983 Phase 2
0.7963 Intermediate Similarity NPD5696 Approved
0.7951 Intermediate Similarity NPD7078 Approved
0.7917 Intermediate Similarity NPD6370 Approved
0.7909 Intermediate Similarity NPD5225 Approved
0.7909 Intermediate Similarity NPD4633 Approved
0.7909 Intermediate Similarity NPD5211 Phase 2
0.7909 Intermediate Similarity NPD5224 Approved
0.7909 Intermediate Similarity NPD5226 Approved
0.7869 Intermediate Similarity NPD6336 Discontinued
0.7863 Intermediate Similarity NPD6274 Approved
0.7857 Intermediate Similarity NPD4768 Approved
0.7857 Intermediate Similarity NPD4767 Approved
0.785 Intermediate Similarity NPD5695 Phase 3
0.7838 Intermediate Similarity NPD5175 Approved
0.7838 Intermediate Similarity NPD5174 Approved
0.7833 Intermediate Similarity NPD6015 Approved
0.7833 Intermediate Similarity NPD6016 Approved
0.7818 Intermediate Similarity NPD5223 Approved
0.7815 Intermediate Similarity NPD7101 Approved
0.7815 Intermediate Similarity NPD7100 Approved
0.7778 Intermediate Similarity NPD4697 Phase 3
0.7769 Intermediate Similarity NPD5988 Approved
0.7768 Intermediate Similarity NPD5141 Approved
0.7731 Intermediate Similarity NPD6335 Approved
0.7724 Intermediate Similarity NPD7507 Approved
0.7719 Intermediate Similarity NPD4730 Approved
0.7719 Intermediate Similarity NPD5345 Clinical (unspecified phase)
0.7719 Intermediate Similarity NPD4729 Approved
0.7714 Intermediate Similarity NPD5328 Approved
0.7714 Intermediate Similarity NPD4753 Phase 2
0.7705 Intermediate Similarity NPD8328 Phase 3
0.7686 Intermediate Similarity NPD6908 Approved
0.7686 Intermediate Similarity NPD6909 Approved
0.7679 Intermediate Similarity NPD4754 Approved
0.7652 Intermediate Similarity NPD8132 Clinical (unspecified phase)
0.7647 Intermediate Similarity NPD7115 Discovery
0.7647 Intermediate Similarity NPD8295 Clinical (unspecified phase)
0.7647 Intermediate Similarity NPD6317 Approved
0.7636 Intermediate Similarity NPD7638 Approved
0.7632 Intermediate Similarity NPD6412 Phase 2
0.7615 Intermediate Similarity NPD5220 Clinical (unspecified phase)
0.7615 Intermediate Similarity NPD5221 Approved
0.7615 Intermediate Similarity NPD5222 Approved
0.7596 Intermediate Similarity NPD6098 Approved
0.7586 Intermediate Similarity NPD5248 Approved
0.7586 Intermediate Similarity NPD5247 Approved
0.7586 Intermediate Similarity NPD5251 Approved
0.7586 Intermediate Similarity NPD5249 Phase 3
0.7586 Intermediate Similarity NPD5250 Approved
0.7583 Intermediate Similarity NPD6314 Approved
0.7583 Intermediate Similarity NPD6313 Approved
0.7573 Intermediate Similarity NPD4786 Approved
0.757 Intermediate Similarity NPD6079 Approved
0.7568 Intermediate Similarity NPD7640 Approved
0.7568 Intermediate Similarity NPD7639 Approved
0.7565 Intermediate Similarity NPD5128 Approved
0.7547 Intermediate Similarity NPD6904 Approved
0.7547 Intermediate Similarity NPD6080 Approved
0.7547 Intermediate Similarity NPD6673 Approved
0.7545 Intermediate Similarity NPD5173 Approved
0.7541 Intermediate Similarity NPD6291 Clinical (unspecified phase)
0.754 Intermediate Similarity NPD7319 Approved
0.7523 Intermediate Similarity NPD6356 Clinical (unspecified phase)
0.7523 Intermediate Similarity NPD5210 Approved
0.7523 Intermediate Similarity NPD4629 Approved
0.75 Intermediate Similarity NPD4202 Approved
0.746 Intermediate Similarity NPD6033 Approved
0.7453 Intermediate Similarity NPD6672 Approved
0.7453 Intermediate Similarity NPD5737 Approved
0.7431 Intermediate Similarity NPD7748 Approved
0.7429 Intermediate Similarity NPD5330 Approved
0.7429 Intermediate Similarity NPD6409 Approved
0.7429 Intermediate Similarity NPD6684 Approved
0.7429 Intermediate Similarity NPD3618 Phase 1
0.7429 Intermediate Similarity NPD7334 Approved
0.7429 Intermediate Similarity NPD7146 Approved
0.7429 Intermediate Similarity NPD7521 Approved
0.7417 Intermediate Similarity NPD6868 Approved
0.7407 Intermediate Similarity NPD8035 Phase 2
0.7407 Intermediate Similarity NPD8034 Phase 2
0.7387 Intermediate Similarity NPD7902 Approved
0.7379 Intermediate Similarity NPD3667 Approved
0.7373 Intermediate Similarity NPD5217 Approved
0.7373 Intermediate Similarity NPD5215 Approved
0.7373 Intermediate Similarity NPD5216 Approved
0.7333 Intermediate Similarity NPD5329 Approved
0.7311 Intermediate Similarity NPD6053 Discontinued
0.729 Intermediate Similarity NPD6903 Approved
0.729 Intermediate Similarity NPD7513 Clinical (unspecified phase)
0.7288 Intermediate Similarity NPD5134 Clinical (unspecified phase)
0.7288 Intermediate Similarity NPD5169 Approved
0.7288 Intermediate Similarity NPD5135 Approved
0.7258 Intermediate Similarity NPD8033 Approved
0.725 Intermediate Similarity NPD8133 Approved
0.7248 Intermediate Similarity NPD7515 Phase 2
0.7248 Intermediate Similarity NPD6050 Approved
0.7248 Intermediate Similarity NPD5693 Phase 1
0.7238 Intermediate Similarity NPD3666 Approved
0.7238 Intermediate Similarity NPD3133 Approved
0.7238 Intermediate Similarity NPD3665 Phase 1
0.7238 Intermediate Similarity NPD4197 Approved
0.7236 Intermediate Similarity NPD7516 Approved
0.7227 Intermediate Similarity NPD5127 Approved
0.7203 Intermediate Similarity NPD4061 Clinical (unspecified phase)
0.7177 Intermediate Similarity NPD8377 Approved
0.7177 Intermediate Similarity NPD8294 Approved
0.717 Intermediate Similarity NPD7520 Clinical (unspecified phase)
0.7156 Intermediate Similarity NPD5692 Phase 3
0.7154 Intermediate Similarity NPD7328 Approved
0.7154 Intermediate Similarity NPD7327 Approved
0.7143 Intermediate Similarity NPD5955 Clinical (unspecified phase)
0.712 Intermediate Similarity NPD8380 Approved
0.712 Intermediate Similarity NPD8379 Approved
0.712 Intermediate Similarity NPD6921 Approved
0.712 Intermediate Similarity NPD8335 Approved
0.712 Intermediate Similarity NPD8378 Approved
0.712 Intermediate Similarity NPD8296 Approved
0.7117 Intermediate Similarity NPD6001 Approved
0.7117 Intermediate Similarity NPD7901 Clinical (unspecified phase)
0.7117 Intermediate Similarity NPD7900 Approved
0.7091 Intermediate Similarity NPD6411 Approved
0.7091 Intermediate Similarity NPD5281 Approved
0.7091 Intermediate Similarity NPD5284 Approved
0.7091 Intermediate Similarity NPD5694 Approved
0.7049 Intermediate Similarity NPD5167 Approved
0.7048 Intermediate Similarity NPD4223 Phase 3
0.7048 Intermediate Similarity NPD4221 Approved
0.6984 Remote Similarity NPD7503 Approved
0.6983 Remote Similarity NPD7632 Discontinued
0.6975 Remote Similarity NPD6686 Approved
0.6975 Remote Similarity NPD5168 Approved
0.6972 Remote Similarity NPD5208 Approved
0.6944 Remote Similarity NPD5279 Phase 3
0.6944 Remote Similarity NPD5280 Approved
0.6944 Remote Similarity NPD4694 Approved
0.6944 Remote Similarity NPD5690 Phase 2
0.6944 Remote Similarity NPD3574 Clinical (unspecified phase)
0.6916 Remote Similarity NPD3668 Phase 3
0.6909 Remote Similarity NPD5764 Clinical (unspecified phase)
0.6909 Remote Similarity NPD6101 Approved
0.6891 Remote Similarity NPD7899 Clinical (unspecified phase)
0.6891 Remote Similarity NPD5954 Clinical (unspecified phase)
0.6887 Remote Similarity NPD6435 Approved
0.6881 Remote Similarity NPD3573 Approved
0.6881 Remote Similarity NPD7524 Approved
0.6875 Remote Similarity NPD5779 Approved
0.6875 Remote Similarity NPD6067 Discontinued
0.6875 Remote Similarity NPD5778 Approved
0.687 Remote Similarity NPD4225 Approved
0.6864 Remote Similarity NPD8170 Clinical (unspecified phase)
0.6857 Remote Similarity NPD7525 Registered
0.685 Remote Similarity NPD8515 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data